GB712547A - Antibiotic and methods of obtaining same - Google Patents

Antibiotic and methods of obtaining same

Info

Publication number
GB712547A
GB712547A GB7415/52A GB741552A GB712547A GB 712547 A GB712547 A GB 712547A GB 7415/52 A GB7415/52 A GB 7415/52A GB 741552 A GB741552 A GB 741552A GB 712547 A GB712547 A GB 712547A
Authority
GB
United Kingdom
Prior art keywords
methanol
water
antibiotic
culture
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7415/52A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Publication of GB712547A publication Critical patent/GB712547A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An antibiotic sistomycosin is produced by inoculating a nutrient medium with Streptomyces viridosporus NRRL 2414, which is described, incubating the inoculated medium under aerobic conditions at a temperature of 20-35 DEG C. for 1 to 8 days and isolating the antibiotic so produced from the culture mixture. The medium may be liquid or solid, the culture submerged or surface. It is preferred to use an aqueous nutrient containing a source of assimilable carbon, proteinaceous material and mineral salts, having initial pH 6-8.2, especially 7.3-7.7, and submerged culture with aeration by air, oxygen, or an oxygen-containing gas at 25-28 DEG C. for 1-4 days. Light should be excluded. The air may be injected into the medium, or the medium may be sprayed into the sterile air. Suitable carbon sources are arabinose, fructose, galactose, lactose, maltose, rhamnose, xylose, glycerol, mannitol and glucose, starch, dextrin, fermentation and distillers' slops, corn steep water solids, corn steep liquor and fermentation residues, e.g. of butanol-acetone. Suitable proteinaceous materials are beef extract, acid hydrolysed casein, beef peptone, soybean oil meal, dried fermentation residues; water-soluble, defatted and partially hydrolysed soybean meal, mixed amino acids, urea and purines. Minerals are sodium chloride, calcium carbonate, monopotassium hydrogen phosphate and di-potassium hydrogen phosphate. The antibiotic is obtained from (a) the liquid culture by first filtering off the mycelium, and from (b) the solid culture by first extracting with a solvent such as water or methanol. The liquids so obtained are extracted with a water-immiscible alcohol, e.g. n-butanol, the solvent removed and the solid extract treated with a fat solvent such as chloroform. The residue is extracted with chloroform containing 10 per cent methanol, and the solution so formed passed down a column of a silicate ion-exchanger. The column is washed with chloroform-methanol of increasing methanol content, and then eluted with methanol. The residue after the removal of the methanol is extracted with water, and the antibiotic recovered by freeze drying. Sistomycosin is a neutral substance, effective in inhibiting the growth of eumycetes and having no effect on the growth of most gram-negative and gram-positive bacteria, and containing only C, H, O and N. It is soluble in water and methanol, less soluble in wet acetone and aqueous alcohols containing more than one carbon atom per molecule; insoluble in chloroform, diethyl ether, ethyl acetate, benzene and petroleum ether. Decomposed by light, it reduces cold aqueous potassium permanganate solution and boiling Benedict's solution; gives a positive Molisch test, a negative ferric chloride test, imparts a deep cherry-red-to-chocolate colour to warm concentrated sulphuric acid, no colour with hydrochloric acid and thymol. In water, it exhibits characteristic maximum and minimum absorption bands in the ultra-violet region of the spectrum. In a hydrocarbon oil, it shows a characteristic infra-red absorption spectrum.
GB7415/52A 1951-03-26 1952-03-21 Antibiotic and methods of obtaining same Expired GB712547A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1057122XA 1951-03-26 1951-03-26

Publications (1)

Publication Number Publication Date
GB712547A true GB712547A (en) 1954-07-28

Family

ID=22307386

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7415/52A Expired GB712547A (en) 1951-03-26 1952-03-21 Antibiotic and methods of obtaining same

Country Status (5)

Country Link
CH (1) CH298331A (en)
DE (1) DE916574C (en)
DK (1) DK87962C (en)
FR (1) FR1057122A (en)
GB (1) GB712547A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3240787A (en) * 1962-01-23 1966-03-15 Inst Medical Res Alpha-hydroxymethyl-n-[omega-hydroxamic-acid-ethylene-carbonylamino-methylene-carbonyl]-pyrrolidine and process for its production
FR2777571A1 (en) * 1998-04-21 1999-10-22 Revico Fermentative production of compounds of economic interest, especially flavors such as gamma-decalactone
US6518050B1 (en) 1998-04-21 2003-02-11 Revico Process for producing and extracting aromatic compounds
WO2009138994A1 (en) * 2008-05-14 2009-11-19 Biocon Limited A fermentation process for the production of secondary metabolites

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3240787A (en) * 1962-01-23 1966-03-15 Inst Medical Res Alpha-hydroxymethyl-n-[omega-hydroxamic-acid-ethylene-carbonylamino-methylene-carbonyl]-pyrrolidine and process for its production
FR2777571A1 (en) * 1998-04-21 1999-10-22 Revico Fermentative production of compounds of economic interest, especially flavors such as gamma-decalactone
US6518050B1 (en) 1998-04-21 2003-02-11 Revico Process for producing and extracting aromatic compounds
WO2009138994A1 (en) * 2008-05-14 2009-11-19 Biocon Limited A fermentation process for the production of secondary metabolites

Also Published As

Publication number Publication date
DK87962C (en) 1959-10-12
DE916574C (en) 1954-10-11
CH298331A (en) 1954-04-30
FR1057122A (en) 1954-03-05

Similar Documents

Publication Publication Date Title
PL98593B1 (en) METHOD OF MAKING THE NEW ANTIBIOTIC THeichomycin 8327
SU578014A3 (en) Method of preparing p,q,r and u rifamycin
Ohno et al. Isolation and characterization of elasnin, a new human granulocyte elastase inhibitor produced by a strain of Streptomyces
GB712547A (en) Antibiotic and methods of obtaining same
GB765886A (en) A new antibiotic ristocetin and a method of producing same
US3616208A (en) Fermentation process for 9-(beta-d-arabinofuranosyl)adenine
GB844289A (en) Pimaricin and process of producing same
SE309955B (en)
Tsuda et al. A new antibiotic, lipopeptin A
US4011140A (en) Process for producing antitumor compound
GB707332A (en) Antibiotics and methods for obtaining same
GB649818A (en) Improvements in or relating to the production of substances obtained by fermentation
Kunc et al. Biological decomposition of fulvic acid preparations
SU1431682A3 (en) Method of producing antibiotic cp-63517 used as fodder additive for cattle and swines
US3119749A (en) Process for preparing 1-dehydro steroids
JP3176433B2 (en) Method for producing zeaxanthin and a novel microorganism of the genus Flexibacter used therein
SU419509A1 (en) METHOD OF OBTAINING TEROFTHAL ACID
GB714189A (en) Antibiotic and method of producing it
US3043830A (en) Actinobolin and its fermentative production
GB793797A (en) Improvements in or relating to antibiotics
EP0478064A2 (en) Microbial preparation of 13beta-13-deoxy-22,23-dihydro avermectin-B1a/B1b aglycone
US3551294A (en) Erythromycin process
US2902480A (en) Process for recovery of antibiotic amicetin
GB758276A (en) A new antibiotic totomycin
US3093543A (en) Antibiotic, flavensomycin, and process for preparing it